Entering text into the input field will update the search result below

Stellar Bio and Neovacs to form JV to make therapeutic vaccines

Jan. 20, 2016 4:17 PM ETEdesa Biotech, Inc. (EDSA) StockEDSABy: Douglas W. House, SA News Editor
  • Stellar Biotechnologies (NASDAQ:SBOT) and Paris, France-based Neovacs S.A. ink a term sheet to form a joint venture to manufacture conjugated therapeutic vaccines using Stellar's Keyhole Limpet Hemocyanin (KLH). The aim of the venture is to produce Neovacs' Kinoid product candidates, including IFNa-Kinoid and other KLH-based immunotherapies, for third party customers.
  • The JV will be 70% owned by Neovacs and 30% owned by Stellar. Additional details or an expected time line are not provided.

Recommended For You

More Trending News

About EDSA Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
EDSA--
Edesa Biotech, Inc.